Chiloiro, Sabrina
 Distribuzione geografica
Continente #
NA - Nord America 1.575
EU - Europa 1.214
AS - Asia 300
SA - Sud America 9
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.108
Nazione #
US - Stati Uniti d'America 1.567
SE - Svezia 280
DE - Germania 269
IT - Italia 263
CN - Cina 150
IE - Irlanda 96
SG - Singapore 91
FR - Francia 58
UA - Ucraina 57
PL - Polonia 54
RU - Federazione Russa 48
GB - Regno Unito 23
FI - Finlandia 21
BE - Belgio 19
IN - India 13
IR - Iran 12
JP - Giappone 12
TR - Turchia 10
CA - Canada 8
CI - Costa d'Avorio 8
HK - Hong Kong 8
NL - Olanda 8
CO - Colombia 4
RO - Romania 4
CZ - Repubblica Ceca 3
BR - Brasile 2
CH - Svizzera 2
PE - Perù 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BG - Bulgaria 1
CL - Cile 1
ES - Italia 1
EU - Europa 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
KR - Corea 1
LI - Liechtenstein 1
MD - Moldavia 1
PT - Portogallo 1
RS - Serbia 1
VN - Vietnam 1
Totale 3.108
Città #
Chandler 410
Ashburn 101
Dublin 83
New York 81
Ann Arbor 78
Fairfield 67
Rome 62
San Mateo 57
Singapore 52
Warsaw 52
Wilmington 51
Bremen 44
Milan 44
Boston 39
Cattolica 38
Marseille 37
Princeton 34
Seattle 34
Moscow 33
Nanjing 26
Houston 23
Jacksonville 23
Chicago 22
Woodbridge 22
Beijing 20
Cambridge 19
Brussels 18
Boardman 16
Redmond 14
Redwood City 13
Hangzhou 12
Mountain View 12
Dearborn 11
Munich 11
Norwalk 11
Augusta 10
Lawrence 10
Helsinki 9
Nürnberg 9
Abidjan 8
Hong Kong 8
Izmir 8
Kish 8
Kunming 8
Los Angeles 8
Washington 8
West Jordan 8
Zhengzhou 8
Guangzhou 7
Nanchang 7
Piacenza 7
Falls Church 6
Fremont 6
Menlo Park 6
Shenyang 6
Andover 5
Lancaster 5
Ottawa 5
Pune 5
Renton 5
Shanghai 5
University Park 5
Cornaredo 4
Hebei 4
Leawood 4
Sakaemachi 4
Bari 3
Brno 3
Campobasso 3
Dalmine 3
Frankfurt am Main 3
Fuzhou 3
Gunzenhausen 3
Jiaxing 3
Krasnodar 3
Mercato San Severino 3
Nuremberg 3
Petrozavodsk 3
Southend 3
Ardabil 2
Azzano Decimo 2
Berlin 2
Bogen 2
Bogotá 2
Buffalo Junction 2
Cesa 2
Chengdu 2
Fort Worth 2
Haikou 2
Jinan 2
Lappeenranta 2
Lima 2
London 2
Meda 2
Medellín 2
Monreale 2
Mumbai 2
Ningbo 2
Osaka 2
Palermo 2
Totale 1.957
Nome #
Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review 228
Hypophysitis Outcome and Factors Predicting Responsiveness to Glucocorticoid Therapy: A Prospective and Double-Arm Study. 228
Typical and Atypical Pituitary Adenomas: A Single-Center Analysis of Outcome and Prognosis 137
Xanthogranuloma of the sellar region: A rare tumor. Case illustration and literature review 126
An Overview of Diagnosis of Primary Autoimmune Hypophysitis in a Single Prospective Monocentric Experience 125
Radically resected pituitary adenomas: prognostic role of Ki67 labeling index in monocentric retrospective series and literature review 97
Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes 94
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: An immunohistochemical study 88
Minichromosome maintenance protein 7 as prognostic marker of tumor aggressiveness in pituitary adenoma patients. 85
The Changing Clinical Spectrum of Hypophysitis 82
Pasireotide and Pegvisomant Combination Treatment in Acromegaly Resistant to Second Line Therapies: A Longitudinal Study 81
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response 77
DIAGNOSIS OF ENDOCRINE DISEASE: Primary Empty Sella: a comprehensive review 74
Synchronous Bilateral Adrenalectomy in ACTH-dependent Hypercortisolism: Predictors, Biomarkers and Outcomes 63
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study. 62
Clinical management of teratoma, a rare hypothalamic-pituitary neoplasia 60
Pancreatic neuroendocrine tumors in MEN1 disease: a mono-centric longitudinal and prognostic study 56
Human leucocyte antigens coeliac haplotypes and primary autoimmune hypophysitis in caucasian patients 56
The changing clinical spectrum of endocrine adverse events in cancer immunotherapy 55
Neuro-radiological features can predict hypopituitarism in primary autoimmune hypophysitis 54
Reappraising the Role of Trans-Sphenoidal Surgery in Prolactin-Secreting Pituitary Tumors. 51
The Role of Growth Hormone Receptor Isoforms and Their Effects in Bone Metabolism and Skeletal Fragility 50
Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review 49
Empty sella syndrome: Multiple endocrine disorders. 49
Growth hormone receptor isoforms and fracture risk in adult-onset growth hormone-deficient patients. 48
Understanding the effect of acromegaly on the human skeleton. 47
Galectin-3 and Estrogen Receptor Alpha as Prognostic Markers in Prolactinoma: Preliminary Results From a Pilot Study 46
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours 46
Short- and long-term responsiveness to low dose growth hormone (GH) in adult GH deficiency: Role of GH receptor polymorphism. 45
Proteomics of Pancreatic Neuroendocrine Tumors: A Systematic Review 45
First Case of Mature Teratoma and Yolk Sac Testis Tumor Associated to Inherited MEN-1 Syndrome. 44
Pleomorphicskin eruptions in a COVID-19 affected patient: Case report and review of the literature 44
Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly. 43
Multidimensional geriatric evaluation in acromegaly: a comparative cross-sectional study 43
Glucose metabolism outcomes in acromegaly patients on treatment with pasireotide-LAR or pasireotide-LAR plus Pegvisomant 43
Autoantibody reactivity profile of primary autoimmune hypophysitis patients: preliminary results 43
Molecular and Genetic Immune Biomarkers of Primary and Immune-Therapy Induced Hypophysitis: From Laboratories to the Clinical Practice 42
Hypothalamitis and pituitary atrophy 40
Prevalence of morphometric vertebral fractures in "difficult" patients with acromegaly with different biochemical outcomes after multimodal treatment. 38
Effects of Pegvisomant and Pasireotide LAR on Vertebral Fractures in Acromegaly Resistant to First-generation SRLs. 38
Acromegaly can be cured by first-line pasireotide treatment? 37
Bone safety of dual-release hydrocortisone in patients with hypopituitarism. 33
Acromegaly in the elderly patients 33
Treatment of Acromegalic Osteopathy in Real-life Clinical Practice: The BAAC (Bone Active Drugs in Acromegaly) Study 31
Pediatric craniopharyngiomas: magnetic resonance imaging assessment for hypothalamus-pituitary axis dysfunction and outcome prediction 26
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin? 26
Interpretable Machine Learning-Based Prediction of Intraoperative Cerebrospinal Fluid Leakage in Endoscopic Transsphenoidal Pituitary Surgery: A Pilot Study 23
Gut Microbiota, LADA, and Type 1 Diabetes Mellitus: An Evolving Relationship 19
Systemic comorbidities of acromegaly in real-life experience: which difference among young and elderly patients? 16
The Pathogenic RET Val804Met Variant in Acromegaly: A New Clinical Phenotype? 16
Pancreas as an Unusual Metastatic Site of Medullary Thyroid Carcinoma: A Case of Very Long-term Follow-up Under Prolonged Treatment with Somatostatin Analogues 15
The immune microenviroment in somatotropinomas: from biology to personalized and target therapy 13
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours 11
Reliability of intraoperative visual evoked potentials (iVEPs) in monitoring visual function during endoscopic transsphenoidal surgery 7
Unveiling the Etiopathogenic Spectrum of Hypophysitis: A Narrative Review 6
From Pituitary Adenoma to Pituitary Neuroendocrine Tumors: How Molecular Pathways may Impact the Therapeutic Management? 6
CD68+ and CD8+ immune cells are associated with the growth pattern of somatotroph tumors and response to first generation somatostatin analogs 5
The multi-biomarker acro-TIME score predicts fg-SRLs response: preliminary results of a retrospective acromegaly cohort 5
Consensus on criteria for acromegaly diagnosis and remission 5
Second line treatment of acromegaly: Pasireotide or Pegvisomant? 4
Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors 4
Markers of humoral and cell-mediated immune response in primary autoimmune hypophysitis: a pilot study 4
Colon Cancer Presenting as Pituitary Mass and Hypopituitarism: Recognition and Multidisciplinary Approach of a Rare Case 4
Cholecalciferol Use Is Associated With a Decreased Risk of Incident Morphometric Vertebral Fractures in Acromegaly 4
Trouillas’s Grading and Post-Surgical Tumor Residue Assessment in Pituitary Adenomas: The Importance of the Multidisciplinary Approach 3
Susceptibility and characteristics of infections in patients with glucocorticoid excess or insufficiency: the ICARO tool 3
Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways 3
Use of 111In-pentetreotide scintigraphy for diagnosis and management of resistant macroprolactinoma 3
Letter: A Multicenter, Propensity Score- Matched Assessment of Endoscopic Versus Microscopic Approaches in the Management of Pituitary Adenomas 3
Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience 2
Trouillas's Grading and Post-Surgical Tumor Residue Assessment in Pituitary Adenomas: The Importance of the Multidisciplinary Approach 2
The Role of Testosterone in Spermatogenesis: Lessons From Proteome Profiling of Human Spermatozoa in Testosterone Deficiency 2
De-escalation treatment with pasireotide for acromegaly: a long-term experience 2
Psychological complications in patients with acromegaly: relationships with sex, arthropathy, and quality of life 2
Partial response to first generation SSA guides the choice and predict the outcome of second line therapy in acromegaly 2
Totale 3.202
Categoria #
all - tutte 15.474
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.474


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020327 60 18 27 47 17 25 49 14 17 14 27 12
2020/2021199 13 16 9 18 23 11 23 2 26 28 28 2
2021/2022474 20 11 6 37 76 25 9 85 23 21 54 107
2022/20231.087 132 153 78 190 56 161 61 78 103 19 27 29
2023/2024658 31 121 23 31 35 113 28 10 39 40 85 102
2024/202529 29 0 0 0 0 0 0 0 0 0 0 0
Totale 3.202